2018-11-05T09:13:24-06:00 2017-12-31 521853933 JONES MARESCA & MCQUADE PA 10500 LITTLE PATUXENT PARKWAY SUITE 770 COLUMBIA MD 21044 990 2017-01-01 043809491 CLINICAL RESEARCH FORUM INC CLIN 2023671176 2025 M STREET NW NO 800 WASHINGTON DC 20036 ANDRE WILLIAMS EXECUTIVE DIRECTOR 2023671176 2018-10-30 1 DAVID JONES P01361002 4108840220 64.88.174.3 2018-10-30 15:56:16 ED P 0087580C7340B0612ABF44AF1D415F2C3C4A590E 0087580C7340B0612ABF44AF1D415F2C3C4A590E 2017 2019-02-21 02:37:17Z ANDRE WILLIAMS 2025 M STREET NW NO 800 WASHINGTON DC 20036 968629 0 X WWW.CLINICALRESEARCHFORUM.ORG X 2005 DE TO PROVIDE LEADERSHIP TO THE NATIONAL CLINICAL AND TRANSLATIONAL RESEARCH ENTERPRISE AND PROMOTE UNDERSTANDING AND SUPPORT FOR CLINICAL RESEARCH AND ITS IMPACT ON HEALTH AND HEALTHCARE. 16 16 0 16 0 0 2500 2650 520308 441239 8307 13365 0 0 531115 457254 5000 5000 0 0 0 0 0 0 0 424439 436736 429439 441736 101676 15518 1020761 1012180 147706 82362 873055 929818 X TO PROVIDE LEADERSHIP TO THE NATIONAL CLINICAL AND TRANSLATIONAL RESEARCH ENTERPRISE AND PROMOTE UNDERSTANDING AND SUPPORT FOR CLINICAL RESEARCH AND ITS IMPACT ON HEALTH AND HEALTHCARE. 0 0 89415 5000 TOP TEN CLINICAL RESEARCH ACHEIVEMENT AWARDS - THE TOP TEN CLINICAL RESEARCH ACHIEVEMENT AWARDS HONOR OUTSTANDING ACCOMPLISHMENTS AND MAJOR ADVANCES RESULTING FROM THE NATION'S INVESTMENT IN RESEARCH TO BENEFIT THE HEALTH AND WELFARE OF ITS CITIZENS. 58145 30000 IT ROUNDTABLE - THE CLINICAL RESEARCH FORUM CONSIDERS THE INTEGRATION OF INFORMATION TECHNOLOGY (IT) AND CLINICAL RESEARCH A HIGH PRIORITY FOR ITS MEMBERS. THE IT ROUNDTABLE WAS INITIATED IN 2005 AND HAS CONTINUED TO BE ONE OF THE FORUM'S MOST ENGAGING INITIATIVES. ROUNDTABLE MEETINGS PROVIDE A VENUE FOR ACADEMIC HEALTH CENTER LEADERS TO SHARE EXPERIENCES AND WORK WITH VENDORS TO ADDRESS KEY IT ISSUES IN CLINICAL RESEARCH SUCH AS THE INTERFACE OF CLINICAL SERVICES AND CLINICAL RESEARCH DATA, WAREHOUSING, DATA SECURITY, ELECTRONIC HEALTH RECORD PLATFORMS, AND GOVERNANCE. 56323 ADVOCACY - THE CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE (CCTS) IS THE UNIFIED VOICE OF THE CLINICAL AND TRANSLATIONAL SCIENCE RESEARCH COMMUNITY, OF WHICH THE CLINICAL RESEARCH FORUM IS A MEMBER. STARTED AS A COALITION OF ORGANIZATIONS WITH A SHARED MISSION TO SUPPORT CLINICAL AND TRANSLATIONAL SCIENCE, CCTS HAS GROWN INTO A NATIONWIDE GRASSROOTS NETWORK OF DEDICATED INDIVIDUALS WHO WORK TOGETHER TO EDUCATE CONGRESS AND THE ADMINISTRATION ABOUT THE VALUE AND IMPORTANCE OF FEDERAL CLINICAL AND TRANSLATIONAL RESEARCH AND RESEARCH TRAINING AND CAREER DEVELOPMENT ACTIVITIES. 46179 10219 ANNUAL MEETING - THE SENIOR LEADERSHIP MEETING IS AN ANNUAL CONVENING OF SENIOR LEADERS FROM ACADEMIC HEALTH CENTER MEMBER INSTITUTIONS. THIS FOCUSED, INTIMATE MEETING INCLUDES AN ADVOCACY AND POLICY UPDATE, INVITED SPEAKERS FROM RELEVANT GOVERNMENT AGENCIES, AND A STRATEGIC PLANNING DISCUSSION FOR THE ORGANIZATION. 27711 399520 MEMBERSHIP 28915 1500 INDUSTRY ROUNDTABLE 102805 411239 306688 0 0 0 1 0 0 0 0 1 0 0 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 10 0 1 0 0 0 0 0 1 1 0 X 16 16 0 1 0 0 1 1 1 1 1 0 0 0 1 1 1 1 1 0 0 0 X SMITHBUCKLIN CORPORATION 2023671176 2025 M STREET NW NO 800 WASHINGTON DC 20036 X HARRY SELKER CHAIR 4.00 X X 0 0 0 HERBERT PARDES VICE-CHAIR 3.00 X X 0 0 0 WILLIAM LOWE JR TREASURER 2.00 X X 0 0 0 LARS BERGLUND DIRECTOR 1.00 X 0 0 0 BARRY COLLER DIRECTOR 1.00 X 0 0 0 ANNE CURTIS DIRECTOR 1.00 X 0 0 0 PAMELA DAVIS DIRECTOR 1.00 X 0 0 0 MAURIZIO FAVA DIRECTOR 1.00 X 0 0 0 HARRY GREENBERG DIRECTOR 1.00 X 0 0 0 REBECCA JACKSON DIRECTOR 1.00 X 0 0 0 ROBERT CALIFF DIRECTOR 1.00 X 0 0 0 E ALBERT REECE DIRECTOR 1.00 X 0 0 0 ARTHUR RUBENSTEIN DIRECTOR 1.00 X 0 0 0 ROBERT SHERWIN DIRECTOR 1.00 X 0 0 0 ANANTHA SHEKHAR DIRECTOR 1.00 X 0 0 0 ARTHUR FELDMAN DIRECTOR 1.00 X 0 0 0 ANDRE WILLIAMS EXECUTIVE DIRECTOR 18.00 X 0 0 0 0 0 0 0 0 0 0 SMITHBUCKLIN CORPORATION 2025 M STREET NW SUITE 800 WASHINGTON DC 20036 MANAGEMENT/ED COMPENSATION 285832 1 2650 2650 MEMBERSHIP DUES 900099 399520 399520 IT ROUNDTABLE 900099 30000 30000 ANNUAL MEETING 900099 10219 10219 INDUSTRY ROUNDTABLE 900099 1500 1500 441239 11980 11980 512760 511375 1385 1385 1385 457254 441239 0 13365 5000 5000 279884 165259 114625 1103 1103 5000 5000 19781 19781 16890 16890 11599 3359 8240 20277 20163 114 76236 76236 4419 4419 LICENSES, FEES AND TAXE 1047 1047 DUES AND SUBSCRIPTIONS 500 500 441736 306688 135048 0 516774 436470 672 16325 5986 7447 497329 551938 1020761 1012180 9466 442 123200 66880 15040 15040 147706 82362 X 784084 836488 88971 93330 873055 929818 1020761 1012180 15518 41245 0 X X 0 1 X 1 0 1 0 0 88971 9359 5000 93330 88666 5305 5000 88971 96948 -3282 5000 88666 98895 3053 5000 96948 93562 10333 5000 98895 1.00000 0 0 0 DUE TO CLINICAL RESEARCH FOUNDATION, A RELATED ENTITY 15040 15040 X PART V, LINE 4: A TEMPORARILY RESTRICTED FUND HAS BEEN ESTABLISHED TO SUPPORT THE HERBERT PARDES CLINICAL RESEARCH EXCELLENCE AWARD. PER THE DONOR'S INSTRUCTIONS, THE CONTRIBUTED FUNDS AND RELATED EARNINGS THEREON ARE REQUIRED TO BE SEGREGATED IN A SEPARATE INVESTMENT ACCOUNT TO PAY A $5,000 ANNUAL AWARD. HOWEVER, IN THE EVENT THE INVESTED FUNDS DO NOT GENERATE SUFFICIENT INCOME IN A GIVEN YEAR, THE ORGANIZATION IS AUTHORIZED TO EXPEND ADDITIONAL FUNDS FROM THE RELATED INVESTMENTS TO MAKE AN AWARD. PART X, LINE 2: THE ORGANIZATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN, AND AS SUCH, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS OR THAT WOULD HAVE AN EFFECT ON ITS TAX-EXEMPT STATUS. THERE ARE NO UNRECOGNIZED TAX BENEFITS OR LIABILITIES THAT NEED TO BE RECORDED. FORM 990, PART VI, SECTION A, LINE 3 THE CLINICAL RESEARCH FORUM, INC. (CRF) HAS ENTERED INTO A MANAGEMENT CONTRACT WITH SMITHBUCKLIN CORPORATION. UNDER THE TERMS OF THIS AGREEMENT, CRF MAKES PAYMENTS TO SMITHBUCKLIN WHICH COVER STAFF SALARIES, EXECUTIVE DIRECTOR, AND OTHER OVERHEAD EXPENSES. THE FEES INCURRED BY CRF DURING THE CURRENT FISCAL YEAR WERE $279,884 WHICH WERE BROKEN DOWN AS FOLLOWS: EXECUTIVE MANAGEMENT - $77,250 MEMBERSHIP AND OPERATIONS SERVICES - $125,992 EVENT SERVICES - $28,743 MARKETING AND COMMUNICATIONS - $8,349 CREATIVE AND DESIGN SERVICES - $5,150 FINANCIAL MANAGEMENT AND ACCOUNTING - $16,500 AMPS PLATFORM AND SUPPORT - $17,096 PROJECT PRINTING AND SUPPORT - $804 SMITHBUCKLIN'S PERFORMANCE UNDER THIS AGREEMENT IS MONITORED BY THE BOARD OF CRF. FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION'S MEMBERS SHALL BE ACADEMIC HEALTH CENTERS THAT ARE INTERESTED IN PARTICIPATING IN THE ACTIVITIES OF THE CORPORATION OR SUPPORTING ITS MISSION AND PURPOSE AND THAT PAY DUES IN ACCORDANCE WITH THE CORPORATION'S REQUIREMENTS. FORM 990, PART VI, SECTION A, LINE 7A DIRECTORS SHALL BE ELECTED BY A PLURALITY OF THE VOTES CAST TO A THREE (3) YEAR TERM BY THE CRF MEMBERS AT THE ANNUAL MEETING OR AT ANY SPECIAL MEETING HELD IN LIEU THEREOF, FROM A SLATE OF ONE (1) OR MORE CANDIDATES SELECTED BY THE NOMINATING COMMITTEE FOR EACH OPEN POSITION. FORM 990, PART VI, SECTION A, LINE 7B EACH CRF MEMBER SHALL HAVE AN EQUAL VOTE AT EVERY MEETING OF THE MEMBERS. UNLESS OTHERWISE PROVIDED BY LAW, THE CERTIFICATE OF INCORPORATION OR THESE BY-LAWS, AN AFFIRMATIVE VOTE OF THE MAJORITY OF THE CRF MEMBERS PRESENT AND ENTITLED TO VOTE SHALL DECIDE EVERY QUESTION. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY MANAGEMENT AND THE BOARD'S FINANCE AND AUDIT COMMITTEE BEFORE IT IS SIGNED AND FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD'S AUDIT COMMITTEE IS RESPONSIBLE FOR ENFORCING COMPLIANCE WITH THE ORGANIZATION'S CONFLICT OF INTEREST POLICY. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE UPON REQUEST. FORM 990, PART XII, LINE 2C: THE ORGANIZATION DID NOT CHANGE ITS AUDIT OVERSIGHT PROCESS OR SELECTION OF AN INDEPENDENT AUDITOR PROCESS DURING THE TAX YEAR. CLINICAL RESEARCH FOUNDATION INC 2025 M STREET NW SUITE 800 WASHINGTON DC 20036 020773588 INACTIVE/FURTHERING EFFECTIVE TRANSLATIONAL RESEARCH DE 501(C)(3) LINE 7 CLINICAL RESEARCH FORUM INC 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0